PubMed Health⌕ Search

PubMed · 9757812

[Basic principles in local dermatologic therapy].

Abstract

The vehicle or ointment base plays an important role in dermatological local treatment. This is true from a therapeutic point of view and with respect to quality of life as well. Vehicles exert pronounced effects on the epidermis; these effects include hydration, lubrication, drying, skin smoothness, occlusion and protection. The vehicle controls the release and penetration, and ultimately the bioavailability, of the dermatological active ingredients. An overly simplified rule of thumb is that a deep-layer effect is enhanced by increasing occlusion. Unfortunately, no uniform classification system exists. Frequently, users of topical applied products are confused by the non-uniform, and in some cases erroneous, vehicle designations. In particular, different names are used to describe the lipophilic emulsion systems. It would be important to consistently use the official designations here: hydrophilic cream or lipophilic (hydrophobic) cream or ointment. Dermatological pastes are also often misleading designated, without any further distinctions, as a uniform occlusive system. For practical applications, attention must be paid in particular to the different indications for hydrophilic and lipophilic vehicles. Hydrophilic, aqueous bases are to be used for acute lesions and seborrhoeic skin, fatty or oily lipophilic systems for dry hyperkeratotic lesions and sebostatic skin. The cosmetic acceptance of a vehicle has a direct impact on both compliance and therapeutic effect. More attention should be paid to these factors. Adverse reactions caused by single components of the vehicle are not unusual. If a lesion does not respond to local treatment, the diagnosis should be reconsidered; moreover, the vehicle and its components should be investigated for possible incompatibility reactions.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

C Pflugshaupt. 1998. [Basic principles in local dermatologic therapy].. https://pubmed.ncbi.nlm.nih.gov/9757812/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Drugs for discoid lupus erythematosus.

BACKGROUND: Discoid lupus erythematosus is a chronic form of cutaneous (skin) lupus which can cause permanent scarring if treatment is inadequate. Many drugs have been used to treat this disease and some of these are potentially very toxic. OBJECTIVES: To assess the effects of drugs for discoid lupus erythematosus. SEARCH STRATEGY: We searched the Cochrane Clinical Trials Register (December 1999), MEDLINE (January 1966 to December 1999), EMBASE (January 1980 to January 2000), and the reference lists of relevant reviews. Index Medicus (1956 to 1966) was handsearched and 7 experts in the field were approached for information about unpublished trials. SELECTION CRITERIA: Randomised trials of drugs to treat people with discoid lupus erythematosus. Drugs included in the search were azathioprine, chloroquine, clofazimine, corticosteroids, (oral and topical), dapsone, gold, interferon alpha-2a, methotrexate, phenytoin, retinoids, sulphasalazine and thalidomide. DATA COLLECTION AND ANALYSIS: Two reviewers independently examined each retrieved study for eligibility. MAIN RESULTS: Two trials involving 136 participants were included. In a cross-over study of twelve weeks duration fluocinonide 0.05% cream (a potent topical corticosteroid), appeared to be markedly better than hydrocortisone 1% cream ( a mild corticosteroid). Clearing or excellent improvement was seen in 27% of people using fluocinonide and in 10% of those using hydrocortisone, giving a 17% absolute benefit in favour of fluocinonide (95% CI 4.5 to 29.5% and NNT 6). In the second trial, hydroxychloroquine was compared with acitretin in 58 people. There was marked improvement or clearing in 46% of people using acitretin and in 50% of those on hydroxychloroquine, a nonsignificant 4% absolute gain with hydroxychloroquine (95%CI -23% to 30%). The adverse effects were more frequent and more severe in the acitretin group. REVIEWER'S CONCLUSIONS: Fluocinonide cream may be more effective than hydrocortisone in treating people with discoid lupus erythematosus. Hydroxychloroquine and acitretin appear to be of equal efficacy, although adverse effects are more frequent and more severe with acitretin. There is not enough reliable evidence about other drugs used to treat discoid lupus erythematosus.

Dermatologic Agents↗

[Granuloma annulare disseminatum: successful therapy with fumaric acid ester].

A 64-year old female patient was treated for a therapy-resistant generalized granuloma annulare with fumaric acid esters (Fumaderm initial). One week following begin of therapy with an initial dose of 30 mg per day, the papules had regressed significantly. A 6-week therapy with a final dose of 90 mg Fumaderm initial per day led to a nearly complete healing of the illness.

Dermatologic Agents↗